During the 5th mRNA-Based Therapeutics Summit Europe 2026 in Berlin find out how Intertek experts can support your mRNA therapy or vaccine, bioanalysis needs, analytical development and drug delivery.
Connect with our team of experts during the 5th mRNA-Based Therapeutics Summit Europe (27th - 29th January 2026) Berlin, Germany.
Intertek can support your mRNA medicines development from early-stage characterisation to late-stage development and commercialisation. We provide mRNA analytical development, including testing for identity, quantity, quality, purity, potency, and process-related impurities. We also offer analytical characterisation of liposome and LNP delivery technologies as well as extractables and leachables for pharmaceutical container closure systems.
Whilst mRNA drugs or vaccines are specific in their mode of action and are typically administered via subcutaneous or intravenous routes, the potential for inhaled or intranasal administration offers a more desirable mode of self-administration, resulting in improved patient experience and compliance. Our scientists provide comrehensive development solutions for inhaled or nasal delivery, including formulation, device selection, compatibility, and analytical development, from both the molecule (structure, physicochemical properties, potency) and delivery performance aspects (delivered dose, delivery rate, aerodynamic droplet size distribution, etc.).
Additionally, our Bioanalytical team provides strong leadership in mRNA preclinical and clinical bioanalytical support through PK/TK & biodistribution, potency & functional assays, immunogenicity & biomarkers, target gene activation/expression, LC-MS, and NMR expertise.
Connect with our team to arrange a meeting.
Our mRNA Analytical Development Resources:
Find out more about our drug development and drug delivery expertise by accessing our technical resources below.
Brochure Download - mRNA Vaccine and Therapeutic Products Analytical Development Services
Brochure Download - mRNA Preclinical and Clinical Bioanalysis Expertise
Presentation - Development Strategies for Inhaled and Nasal Oligonucleotide and mRNA Products
On-Demand Webinar - Superhero Analytics - Understanding the Fantastic Four: Capping Efficiency, Sequencing, Poly-A Tail, dsRNA
Learn more about the event: 5th Annual mRNA-Based Therapeutics Summit
VIDEO mRNA Characterisation, Analysis & GMP Testing Services